On Monday, Compass Point adjusted their outlook on shares of Advanced Flower Capital (NASDAQ: AFCG), increasing the price target to $10.00, up from the previous $9.00, while keeping a Neutral rating on the stock.
The revision reflects the firm's view of the company's potential for earnings growth following strategic financial activities. According to InvestingPro data, AFCG is currently trading at a relatively high earnings multiple with a P/E ratio of 24.39, suggesting the stock may be slightly overvalued compared to its Fair Value.
Advanced Flower Capital completed the spin-off of its commercial real estate (CRE) portfolio on July 9th. In the third quarter, which ended on September 30th, AFCG reported significant financial transactions. The company received $10 million in principal repayments and extended $11 million to a new borrower.
Moreover, AFCG purchased $5 million of principal in a syndicated loan and made amendments to two existing loans that increased commitments by $7 million. Another noteworthy change was the amendment of interest payable on one loan to be paid in kind for July and August, with the expectation that the borrower will resume full cash payments in January 2025.
InvestingPro analysis shows the company maintains strong liquidity with a current ratio of 5.09, indicating robust financial health for continued lending operations.
Following the end of the quarter, AFCG continued its financial activities by funding a $41 million senior secured credit facility to a new borrower and agreeing to purchase $10 million of a senior secured loan to a public company operator through a syndicate. These moves highlight the company's active management of its loan portfolio and commitment to expanding its reach in the cannabis sector.
The earnings power of Advanced Flower Capital's core portfolio has matched Compass Point's expectations set prior to the spin-off. The firm projects that the quarterly Earnings Asset Depreciation (EAD) run rate will support the indicated $0.33 dividend. The increase in the price target to $10.00 is based on the anticipated earnings growth as AFCG continues to deploy capital into core cannabis loans.
Despite the positive outlook on earnings potential, the firm maintains a Neutral stance on the stock. InvestingPro data reveals AFCG offers a substantial 13.57% dividend yield, with the stock showing strong momentum through a 33.32% year-to-date return. Subscribers can access additional insights and 6 more ProTips about AFCG's financial health and growth prospects.
In other recent news, Advanced Flower Capital (AFC) reported robust third-quarter financial results, surpassing its annual target with $116 million in loan originations and reporting distributable earnings of $0.35 per share.
Despite lower-than-expected revenue and operating profit, the company's diluted earnings per share exceeded analyst expectations. TD (TSX:TD) Cowen, maintaining a Buy rating on AFC with a $14.00 price target, noted the company's strategic positioning as a dedicated cannabis sector lender and its ability to navigate the current legislative climate as key strengths.
AFC's management has expressed cautious optimism about the cannabis market, focusing on quality investments and maintaining growth. The company raised $12.2 million through an ATM stock offering and announced a post-spin dividend of $0.33 per share, aligning with its policy to distribute 85% to 100% of distributable earnings. Furthermore, AFC's active pipeline of potential deals exceeds $400 million, indicating robust future prospects.
Despite facing challenges in mature cannabis markets like Illinois and New Jersey, and a trend of cautious lending practices among regional banks, AFC remains strategically positioned. The company anticipates a similar loan origination target for 2025, demonstrating its commitment to capitalize on lending opportunities in the cannabis market. These are some of the recent developments in the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.